In Vitro Human Microbiota Response to Exposure to Silver Nanoparticles Biosynthesized with Mushroom Extract.

The ability to orally administer silver nanoparticles (AgNPs) in enteric capsules implies a direct interaction with the colon microbiota. The in vitro effect provides a portrayal of the functional properties under <italic>in vivo</italic> conditions. The purpose of this study was to describe a green AgNP synthesis process, using aqueous extract from <italic>Lactarius piperatus</italic> mushroom, and to characterize the nanomaterial. We determined its antimicrobial and antioxidant effects <italic>in vitro</italic> in the microbiota of healthy individuals via the GIS1 system—a colon transit simulator. Per the quantitative polymerase chain reaction (qPCR) results, the antimicrobial properties of the AgNPs affected the initial share of different enteric species by decreasing the <italic>Bacteroides</italic>, <italic>Enterobacteriaceae</italic>, and <italic>Lactobacillus</italic> populations and favoring the <italic>Bifidobacterium</italic> group. The association between AgNPs and wild mushroom <italic>L. piperatus</italic> extract had a synergistic antibacterial activity against various pathogenic microorganisms while the mushroom extract reduced biofilm formation. Administration of AgNP maintained its constant antioxidant status, and it was correlated with a reduction in ammonium compounds. The physicochemical characterization of these NPs complemented their biochemical characterization. The maximum ultraviolet-visible spectroscopy (UV-VIS) absorbance was observed at 440 nm, while the Fourier transform infrared (FT-IR) spectrum reached a peak at 3296 cm^–1, which was correlated with the high-performance liquid chromatographic analysis (HPLC). The major phenolic compound was homogentisic acid. The size (49 ± 16 nm in diameter) and spherical shape of the NPs were correlated with their biological effects <italic>in vitro</italic>. [ABSTRACT FROM AUTHOR]